Delivery Order SPE2DB25D3108-SPE2DB25FPBUG

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,950.24 Firm Fixed Price Delivery Order contract is for the provision of TACROLIMUS 0.1% OINTMENT 30GM, a specialty pharmaceutical product. The contract has an ultimate completion date of August 19, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,937.98 firm fixed-price delivery order is for the supply of Tacrolimus 0.1% ointment, a medication used to treat certain skin conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,549.30 firm fixed-price delivery order is for the supply of 30 gram tubes of Tacrolimus 0.1% ointment, with an ultimate completion date of November 18, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,703.25 firm-fixed-price delivery order is for the supply of Tacrolimus 0.1% ointment, a medication used to treat various skin conditions. The contract is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $4,726.89, is for the delivery of Tacrolimus 0.1% Ointment in 30 gram quantities. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...
This contract award to Amerisourcebergen Drug Corp. (a major pharmaceutical distributor) by the Defense Logistics Agency (DLA) Troop Support Medical provides Tacrolimus 0.1% 30g ointment for a total ceiling value of $4,206. The contract is a Firm Fixed Price Delivery Order with a completion date of December 13, 2024. While the award does not have a specific set-aside designation, Amerisourcebergen maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, with an ID of SPE2DB20D3505|SPE2DB24FU5V1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 0.1% Ointment, a pharmaceutical product, with a ceiling value of $1,679.09 and a completion date of July 9, 2024. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug...
This federal contract award is a delivery order (SPE2DX15D6028|SPE2DX25FWFCE) issued by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,355.00, is for the delivery of TACROLIMUS .1% 30GM 1S, a pharmaceutical product, with a completion date of November 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,421.64 Firm Fixed Price Delivery Order is for the supply of 4563503748 - Tacrolimus 0.1% Ointment 60GM. The contract has a completion date of February 1, 2024 and was awarded on January 31, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor, holds a significant $999,999,999...
This federal contract award is for the delivery of Tacrolimus 0.1% ointment, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,419.87, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00,...
  • SPE2DB25D3108
    Indefinite Delivery Contract
  • SPE2DB25D3108-SPE2DB25FPBUG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,224.06 firm fixed-price delivery order is for the supply of TACROLIMUS 0.1% OINTMENT 60GM.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract does not have a set-aside designation, indicating open competition. The award has an ultimate completion date of January 6, 2025.

Generated 4/4/25, 9:57 AM